ALISO VIEJO, Calif., July 29, 2013 (GLOBE NEWSWIRE) -- Avanir Pharmaceuticals, Inc. (Nasdaq:AVNR) will report financial results for the quarter ended June 30, 2013 after market close on Tuesday, August 6, 2013. The company will conduct a conference call and an audio webcast at 1:30 pm Pacific Time (4:30 pm Eastern Time) on the same day.
Conference Call Information:
Domestic callers: 1 (800) 638-4817
International callers: +1 (617) 614-3943
Webcast information: Visit http://ir.avanir.com.
A webcast replay will be available on the Avanir Web site for 30 days. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 1 (888) 286-8010 for domestic callers, or +1 (617) 801-6888 for international callers, and entering reservation code 55240220.
About Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.
AVANIR® is a registered trademark owned by Avanir Pharmaceuticals, Inc.
©2013 Avanir Pharmaceuticals, Inc. All Rights Reserved.
CONTACT: Avanir Investor & Media Contact
Ian Clements, PhD
+1 (949) 389-6700Avanir Pharmaceuticals